A detailed history of Cache Tech Inc. transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Cache Tech Inc. holds 5,893 shares of GILD stock, worth $664,082. This represents 0.12% of its overall portfolio holdings.

Number of Shares
5,893
Holding current value
$664,082
% of portfolio
0.12%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Sep 25, 2025

BUY
$96.91 - $113.0 $571,090 - $665,909
5,893 New
5,893 $653 Million

Others Institutions Holding GILD

About GILEAD SCIENCES, INC.


  • Ticker GILD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,253,369,984
  • Market Cap $141B
  • Description
  • Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...
More about GILD
Track This Portfolio

Track Cache Tech Inc. Portfolio

Follow Cache Tech Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cache Tech Inc., based on Form 13F filings with the SEC.

News

Stay updated on Cache Tech Inc. with notifications on news.